pubblicazioni

New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future.

Expert Opin Ther Targets 2011 [Epud ahead of print]

Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up.

Med Oncol 2011 [epud ahead of print]

Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports).

Oncol Rep 2011;25:113-20

Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?

Colorectal Dis 2011;13:542-8

Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.

J Exp Clin Cancer Res 2010;29:173

The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs).

J Transl Med 2010;8:117

Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes.

Tumori 2010;96:219-28

A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number

Lab Invest 2010;90:1285-94

Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy.

Cancer Treat Rev 2010;36:63-8

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

J Clin Oncol 2009;27:5202-7

Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma

Cancer Res 2009; 69: 2443-52

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model.

Clin Exp Med 2009; 20: 213–226

Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target.

Int J Cancer 2009; 125: 2291-4

Molecular imaging of EGFR: it's time to go beyond receptor expression.

J Nucl Med 2009;50:1195-6

Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review).

Oncol Rep 2009; 21: 1359-1366

The Response Evaluation Criteria in Solid Tumors: until when?

Nucl Med Commun 2009;30:185-7

To widen the setting of cancer patients who could benefit from metronomic capecitabine.

Cancer Chemother Pharmacol 2009;64:189-93

Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives

Cancer Treat Rev 2009; 35: 201–209

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer.

Ann Oncol 2009; 20: 213–226

Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice

Br J Cancer 2008; 99: 1729-34

Centro Interdipartimentale di ricerche sul cancro "Giorgio Prodi"

Un sito per facilitare la comunicazione del lavoro dei ricercatori, sia all'interno che verso l'esterno. Per stimolare la collaborazione, e valorizzare i contenuti.

Policlinico S.Orsola-Malpighi
Padiglione 13, V piano

Via Massarenti, - 40138 Bologna
tel. +39 051 307532; +39 051 6364663
fax. +39 051 349655
email. CIRC@unibo.it
Link utili